CureVac Revenue

Biotechnology Research

Tübingen, Baden-Württemberg, Germany

501-1000 Employees (View 502 on Prospeo)

CureVac revenue & valuation

Annual revenue	$72,200,000
Revenue per employee	$107,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$230,900,000
Total funding	$250,000,000

Overview Emails Format About Employees Insights Funding Tech Stack Trending Companies FAQ

Company overview

Headquarters	Friedrich-Miescher-Str. 15, Tübingen, Baden-Württemberg 72076, DE
Phone number	+4986160390
Website	curevac.com
NAICS	541714
SIC	283
Keywords	Oncology, Research And Development, Manufacturing, Mrna Therapeutics, Cancer Therapies, Prophylactic Vaccines, Molecular Therapies
Founded	2000
Employees	501-1000
Socials

CureVac Email Formats

CureVac uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@curevac.com), used 53.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@curevac.com	53.3%
{first initial}.{last name}	j.doe@curevac.com	45.2%

Get Verified Emails

About CureVac

CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer vaccine product candidates. It also develops programs in prophylactic vaccines and in treatments that enable the human body to produce its own therapeutic proteins. Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.

View contact profiles from CureVac

Employees by Management Level

Total employees: 501-1000

Seniority

Employees

Entry

177

Manager

142

Director

See all employees

Employees by Department

CureVac has 334 employees across 19 departments.

Departments

Number of employees

See all employees

Funding Data

Explore CureVac's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-03-07	14	$250,000,000

Funding Insights

$250,000,000

Total funding amount

$250,000,000

Most recent funding amount

Number of funding rounds

CureVac Tech Stack

Discover the technologies and tools that power CureVac's digital infrastructure, from frameworks to analytics platforms.

Vimeo

Video players

WP Rocket

Caching

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Google Analytics

Analytics

WPML

Translation

See all 24 technologies

Frequently asked questions

CureVac is located in Tübingen, Baden-Württemberg, DE.

You can reach CureVac at +4986160390.

CureVac generates an estimated annual revenue of $72,137,020. This revenue figure reflects the company's market position and business performance in its industry.

CureVac has an estimated valuation of $230,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CureVac was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

CureVac has approximately 501-1000 employees. The company continues to grow its workforce to support its business operations and expansion.

CureVac has raised a total of $250,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at CureVac

Alexander Zehnder

Chief Executive Officer

@curevac.com

4.8

40,000 users